Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 29, 2012 - Issue 6
Submit an article Journal homepage
319
Views
8
CrossRef citations to date
0
Altmetric
SOLID TUMORS

The Treatment of Retinoblastoma with Four-Drug Regimen Including Cisplatin, Etoposide, Vincristine, and Cyclophosphamide

Ali VaranDepartment of Pediatric Oncology, Institute of Oncology, Hacettepe University, Ankara, TurkeyCorrespondence[email protected]
,
Hayyam KiratliOcular Oncology Service, Department of Ophthalmology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
,
Burca AydınDepartment of Pediatric Oncology, Institute of Oncology, Hacettepe University, Ankara, Turkey
,
Berçin TarlanOcular Oncology Service, Department of Ophthalmology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
,
Cigdem Beyhan PoyrazOcular Oncology Service, Department of Ophthalmology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
,
Canan AkyüzDepartment of Pediatric Oncology, Institute of Oncology, Hacettepe University, Ankara, Turkey
&
Münevver BüyükpamukçuDepartment of Pediatric Oncology, Institute of Oncology, Hacettepe University, Ankara, Turkey
 show all
Pages 529-537 | Received 26 Dec 2011, Accepted 01 Jun 2012, Published online: 03 Jul 2012

REFERENCES

  • Shields CL, Mashayekhi A, Cater J, Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors. Trans Am Ophthalmol Soc. 2004;102:35–45.
  • Shields CL, Shields JA. Diagnosis and management of retinoblastoma. Cancer Control. 2004;11:317–327.
  • Shields CL, Mashayekhi A, Demirci H, Practical approach to management of retinoblastoma. Arch Ophthalmol. 2004;122:729–735.
  • Chantada GL, Fandino AC, Raslawski EC, Experience with chemoreduction and focal therapy for intraocular retinoblastoma in a developing country. Pediatr Blood Cancer. 2005;44:455–460.
  • Chantada G, Fandino A, Davila MTG, Results of a prospective study for the treatment of retinoblastoma. Cancer. 2004;100:834–842.
  • Rodriguez-Galindo C, Wilson MW, Haik BG, Treatment of intraocular retinoblastoma with vincristine and carboplatin. J Clin Oncol. 2003;21:2019–2025.
  • Shields CL, Shields JA, Needle M, Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology. 1997;104:2101–2111.
  • Shields CL, De Potter P, Himelstein BP, Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol. 1996;14:1330–1338.
  • Sussman DA, Escalona-Benz E, Benz MS, Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy. Arch Ophthalmol. 2003;121:979–984.
  • Ghose S, Nizamuddin SH, Sethi A, Efficacy of induction chemotherapy in retinoblastoma, alone or combined with other adjuvant modalities. J Pediatr Ophthalmol Strabismus. 2002;39:143–150.
  • Murphree AL, Villablanca JG, Deegan WF, 3rd, Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol. 1996;114:1348–1356.
  • Chantada GL, Dunkel IJ, Abramson DH. Management of high risk retinoblastoma. Expert Rev Ophthalmol. 2012;7:61–72.
  • Friedman DL, Himelstein B, Shields CL, Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol. 2000;18:12–17.
  • Murphree AL. Intraocular retinoblastoma: the case for a new classification. Ophthalmol Clin N Am. 2005;18:41–53.
  • Shields CL, Mashayekhi A, Cater J, Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors. Am J Ophthalmol. 2004;138:329–337.
  • Peto R, Pike MC, Armitage P, Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer. 1977;35:1–39.
  • Gündüz K, Günalp I, Yalçındağ N, Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Ophthalmology. 2004;111:1917–1924.
  • Shields CL, Meadows AT, Leahey AM, Shields JA. Continuing challenges in the management of retinoblastoma with chemotherapy. Retina. 2004;24:849–862.
  • Shields CL, Shelil A, Cater J, Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients. Arch Ophthalmol. 2003;121:1571–1576.
  • Chantada GL, Fandino AC, Guitter MR, Results of a prospective study for the treatment of unilateral retinoblastoma. Pediatr Blood Cancer. 2010;55:60–66.
  • Shields CL, Honavar SG, Shields JA, Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma. Arch Ophthalmol. 2002;120:460–464.
  • Shields CL, Shields JA, Cater J, Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors. Ophthalmology. 2001;108:2116–2121.
  • Shields CL, Santos MC, Diniz W, Thermotherapy for retinoblastoma. Arch Ophthalmol. 1999;117:885–893.
  • Schiavetti A, Hadjistilianou T, Clerico A, Conservative therapy in intraocular retinoblastoma: response/recurrence rate. J Pediatr Hematol Oncol. 2005;27:3–6.
  • Zage PE, Reitman A, Seshadri R, Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma. Pediatr Blood Cancer. 2008;50:567–572.
  • Kebudi R, Ayan İ, Cantürk Ş, Chemoreduction and local ophthalmic therapies in intraocular retinoblastoma. Pediatr Blood Cancer. 2007;49:485.
  • Leal-Leal C, Flores-Rojo M, Medina-Sanson A, A multicentre report from the Mexican Retinoblastoma Group. Br J Ophthalmol. 2004;88:1074–1077.
  • Zhao J, Dimaras H, Massey C, Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis. J Clin Oncol. 2011;29:845–851.
  • Chantada G, Leal-Leal C, Brisse H, Is it pre-enucletiaon chemotherapy or delayed enucleation of severely involved eyes with intraocular retinoblastoma that risks extraocular dissemination and death? J Clin Oncol. 2011;29:3333–3334.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.